Multisubstituted quinoxalines and pyrido[2,3-d]pyrimidines: Synthesis and SAR study as tyrosine kinase c-Met inhibitors

被引：30

作者：

Wu, Kui ^{[1
]}

Ai, Jing ^{[2
]}

Liu, Qiufeng ^{[3
]}

Chen, TianTian ^{[3
]}

Zhao, Ailing ^{[4
]}

Peng, Xia ^{[2
]}

Wang, Yuanxiang ^{[4
]}

Ji, Yinchun ^{[2
]}

Yao, Qizheng ^{[1
]}

Xu, Yechun ^{[3
]}

Geng, Meiyu ^{[2
]}

Zhang, Ao ^{[4
]}

机构：

[1] China Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Peoples R China

[2] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China

[3] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China

[4] Chinese Acad Sci, Shanghai Inst Mat Med, Synthet Organ & Med Chem Lab, Shanghai 201203, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2012年 / 22卷 / 20期

基金：

中国国家自然科学基金; 美国国家科学基金会;

关键词：

c-Met kinase; 3,5-Diamino-7-trifluoroquinoline; hERG; Antitumor activity; Structure-activity relationship (SAR); SCATTER-FACTOR; GROWTH; METASTASIS; POTENT;

D O I：

10.1016/j.bmcl.2012.08.075

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Two series of new analogues were designed by replacing the quinoline scaffold of our earlier lead 2 (zgw-atinib) with quinoxaline and pyrido[2,3-d]pyrimidine frameworks. Moderate c-Met inhibitory activity was observed in the quinoxaline series. Among the pyrido[2,3-d]pyrimidine series, compounds 13a-c possessing an O-linkage were inactive, whilst the N-linked analogues 15a-c retained c-Met inhibitory potency. Highest activity was observed in the 3-nitrobenzyl analog 15b that showed an IC50 value of 6.5 nM. Further structural modifications based on this compound were undergoing. (c) 2012 Elsevier Ltd. All rights reserved.

引用

页码：6368 / 6372

页数：5

共 50 条

[31] SYNTHESIS OF NOVEL CONDENSED PYRIDINES AND PYRIDO[2,3-d]PYRIMIDINES
Paronikyan, E. G.
Noravyan, A. S.
Harutunyan, A. S.
CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2010, 46 (08) : 987 - 990
[32] A three-component synthesis of pyrido[2,3-d]pyrimidines
Mont, N
Teixidó, J
Borrell, JI
Kappe, CO
TETRAHEDRON LETTERS, 2003, 44 (29) : 5385 - 5387
[33] SYNTHESIS OF 4-PHENYL-PYRIDO[2,3-D]PYRIMIDINES
SOLLHUBERKRETZER, M
TROSCHUTZ, R
ARCHIV DER PHARMAZIE, 1983, 316 (04) : 346 - 352
[34] Synthesis of pyrano[2,3-d]pyrimidines and pyrido[2,3-d]pyrimidines in the magnetized deionized water based on UV-visible study
Bakherad, Mohammad
Bagherian, Ghadamali
Rezaeifard, Amin
Mosayebi, Fatemeh
Shokoohi, Behzad
Keivanloo, Ali
JOURNAL OF THE IRANIAN CHEMICAL SOCIETY, 2021, 18 (04) : 839 - 852
[35] Clean synthesis of pyrido[2,3-d]pyrimidines in aqueous media
Shi, DQ
Niu, LH
Zhuang, QY
JOURNAL OF CHEMICAL RESEARCH, 2005, (10) : 648 - 650
[36] PYRANO ( 2,3,-D ) - + PYRIDO ) 2,3-D . PYRIMIDINES
SCARBOROUGH, HC
JOURNAL OF ORGANIC CHEMISTRY, 1964, 29 (01): : 219 - &
[37] Synthesis and SAR of diaminopyrimidines as c-Met inhibitors
Weinberg, Linda R.
Albom, Mark S.
Angeles, Thelma S.
Diebold, James L.
Husten, Jean
Lisko, Joseph G.
Milkiewicz, Karen L.
Murthy, Seetha
Ott, Gregory R.
Ruggeri, Bruce A.
Theroff, Jay P.
Underiner, Ted L.
Dorsey, Bruce D.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[38] PYRIDO[2,3-D]PYRIMIDINES .5. REACTION OF CHLOROPYRIDO[2,3-D]PYRIMIDINES WITH DMSO
BYSTRYAKOVA, ID
BUROVA, OA
SMIRNOVA, NM
SAFONOVA, TS
KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII, 1991, (11): : 1563 - 1564
[39] The synthesis and SAR of 2-amino-pyrrolo[2,3-d]pyrimidines:: A new class of Aurora-A kinase inhibitors
Moriarty, Kevin J.
Koblish, Holly K.
Garrabrant, Thomas
Maisuria, Jahanvi
Khalil, Ehab
Ali, Farah
Petrounia, Loanna P.
Crysler, Carl S.
Maroney, Anna C.
Johnson, Dana L.
Galemmo, Robert A., Jr.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (22) : 5778 - 5783
[40] THE SYNTHESIS AND TRANSFORMATIONS OF 3-ETHOXYCARBONYL-2-ISOTHIOCYANATOPYRIDINE - PYRIDO[2,3-D]PYRIMIDINES AND SOME AZOLOPYRIDO[2,3-D]PYRIMIDINES
URLEB, U
STANOVNIK, B
TISLER, M
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1990, 27 (03) : 643 - 646

← 1 2 3 4 5 →